| Name | PAβN dihydrochloride |
| Description | PAβN dihydrochloride (MC-207,110 dihydrochloride) is an inhibitor of efflux pump. |
| In vitro | PAβN reduces the MICs in nine ciprofloxacin-resistant isolates, and in four of these, PAβN increases the susceptibility by twofold. Moreover, PAβN restores ciprofloxacin susceptibility in five of the ciprofloxacin-resistant isolates. In addition, clear effects of NMP on the ciprofloxacin MICs are seen for 20 of these ciprofloxacin-resistant isolates[2]. |
| Storage | Store at low temperature,Keep away from moisture | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : 14.29 mg/mL (27.51 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (6.35 mM), Sonication is recommended. DMSO : 95 mg/mL (182.88 mM), Sonication is recommended.
|
| Keywords | Phe-Arg-β-naphthylamide Dihydrochloride | Phe-Arg-β-naphthylamide | Phe-Arg-b-naphthylamide Dihydrochloride | Phe-Arg-b-naphthylamide | Phe-Arg-beta-naphthylamide Dihydrochloride | Phe-Arg-beta-naphthylamide | PAβN dihydrochloride | PAβN | PAbN Dihydrochloride | PAbN | PAbetaN Dihydrochloride | PAbetaN | MC-207,110 Dihydrochloride | MC-207,110 | Inhibitor | inhibit | efflux pump | Bacterial |
| Inhibitors Related | Neomycin sulfate | Adipic dihydrazide | Levulinic acid | D(+)-Raffinose pentahydrate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Doxycycline | Hyaluronic acid sodium (MW 20 kDa) | Dimethyl sulfoxide | Sodium diacetate | Sodium bicarbonate | BES |
| Related Compound Libraries | Bioactive Compound Library | Peptide Compound Library | Inhibitor Library | NO PAINS Compound Library | Anti-Bacterial Compound Library | Bioactive Compounds Library Max | Anti-Infection Compound Library |